These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3607787)

  • 1. Phase II trial of esorubicin in the treatment of metastatic carcinoma of the kidney: a study of the Northern California Oncology Group.
    Carlson RW; Williams RD; Billingham ME; Kohler M; Torti FM
    Cancer Treat Rep; 1987; 71(7-8):767-8. PubMed ID: 3607787
    [No Abstract]   [Full Text] [Related]  

  • 2. Esorubicin in refractory metastatic carcinoma of the breast: a Northern California Oncology Group Study.
    Carlson RW; Billingham ME; Kohler M; Johnson FD; Doroshow JH; Torti FM
    Cancer Treat Rep; 1987 Apr; 71(4):427-8. PubMed ID: 3548961
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II trial of 4'-epi-doxorubicin in advanced colorectal carcinoma: a Northern California Oncology Group study.
    Meyers FJ; Lewis B; Mitchell E; William L; Hannigan JF; Gribble M; Torti FM
    Cancer Treat Rep; 1985 Jan; 69(1):143-4. PubMed ID: 3855385
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II study of esorubicin in patients with advanced colorectal carcinoma and no prior chemotherapy: an Illinois Cancer Council Trial.
    Locker GY; Hoeltgen T; Kilton L; Krauss S; McNamara M; Blough R; Johnson C
    Cancer Treat Rep; 1987; 71(7-8):765-6. PubMed ID: 3300969
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
    Fiore J; Kemeny N; Raymond V; Young C
    Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II study of 4'-epi-doxorubicin in metastatic renal cancer.
    Fosså SD; Wik B; Bae E; Lien HH
    Cancer Treat Rep; 1982 May; 66(5):1219-21. PubMed ID: 6952962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of esorubicin in patients with advanced melanoma.
    Frustaci S; Gasparini G; Galligioni E; Tirelli U; Di Pietro N; Crivellari D; Lo Re G; Monfardini S
    Cancer Treat Rep; 1987 Mar; 71(3):325-6. PubMed ID: 3815399
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial of Baker's antifol in metastatic renal cell carcinoma: a Southwest Oncology Group Study.
    Bukowski RM; LoBuglio A; McCracken J; Pugh R
    Cancer Treat Rep; 1980; 64(12):1387-8. PubMed ID: 7471126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European Organization for Research and Treatment of Cancer (EORTC) phase II study of low-dose weekly epirubicin in metastatic prostate cancer.
    Jones WG; Fosså SD; Bono AV; Klijn JG; De Pauw M; Sylvester R
    Cancer Treat Rep; 1987 Dec; 71(12):1317-8. PubMed ID: 3480046
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II trial of esorubicin in advanced renal carcinoma. Clinical Screening Group of the EROTC.
    Hurteloup P; Chollet P; Roche H; Chevallier B; Cappelaere P; Van Glabbece M; Hayat M; Armand JP
    Eur J Cancer Clin Oncol; 1989 Jun; 25(6):995-6. PubMed ID: 2753061
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial of 4'-epi-doxorubicin in advanced carcinoma of head and neck origin.
    Magee MJ; Howard J; Bosl GJ; Wittes RE
    Cancer Treat Rep; 1985 Jan; 69(1):125-6. PubMed ID: 3855384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II clinical trial of pegylated liposomal doxorubicin (JNS002) in Japanese patients with mullerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of fallopian tube, peritoneal carcinoma) having a therapeutic history of platinum-based chemotherapy: a Phase II Study of the Japanese Gynecologic Oncology Group.
    Katsumata N; Fujiwara Y; Kamura T; Nakanishi T; Hatae M; Aoki D; Tanaka K; Tsuda H; Kamiura S; Takehara K; Sugiyama T; Kigawa J; Fujiwara K; Ochiai K; Ishida R; Inagaki M; Noda K
    Jpn J Clin Oncol; 2008 Nov; 38(11):777-85. PubMed ID: 18927230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II evaluation of esorubicin in ovarian cancer. A Southwest Oncology Group study.
    Alberts DS; Mason-Liddil N; Stock-Novack D; O'Toole RV; Abbott TM; Salmon SE
    Am J Clin Oncol; 1992 Apr; 15(2):146-9. PubMed ID: 1553903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of thymosin fraction 5 in the treatment of metastatic renal cell carcinoma.
    Dimitrov NV; Arnold D; Munson J; Singh T; Borst J; Stott P
    Cancer Treat Rep; 1985 Jan; 69(1):137-8. PubMed ID: 3967256
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II trial of doxorubicin therapy for advanced islet cell carcinoma.
    Moertel CG; Lavin PT; Hahn RG
    Cancer Treat Rep; 1982 Jul; 66(7):1567-9. PubMed ID: 6284361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of 1,2,4-triglycidylurazol in patients with metastasized renal cell carcinoma.
    Wagner H; Possinger K; Bremer K; Donhujsen-Ant R; Peukert M; Queisser W
    Cancer Treat Rep; 1987 Feb; 71(2):209-10. PubMed ID: 3802118
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma.
    Braich TA; Salmon SE; Robertone A; Alberts DS; Jones SE; Miller TP; Garewal HS
    Invest New Drugs; 1986; 4(3):269-74. PubMed ID: 3818231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications and results of repeated renal artery doxorubicin infusion in rabbits with VX-2 kidney carcinoma.
    Gadeholt G; Göthlin JH
    Ann Radiol (Paris); 1987; 30(2):138-41. PubMed ID: 3619332
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
    Taylor SA; Von Hoff DD; Baker LH; Balcerzak SP
    Cancer Treat Rep; 1984 Jun; 68(6):919-20. PubMed ID: 6733708
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phase II collaborative study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) for urological malignancies--Urological Co-operative THP Study Group].
    Niijima T; Koyanagi T; Sakashita S; Origasa S; Akaza H; Machida T; Koiso K; Rinsho K; Aso Y; Suzuki K
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):224-31. PubMed ID: 3947104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.